Stonebridge Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-465
Closed -$230K – 323
2026
Q2
$230K Buy
+465
New +$206K 0.03% 267

Other funds holding VRTX

Stonebridge Financial Group's VRTX Position: Q3 2026 in Review

Stonebridge Financial Group sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 465 shares — an estimated $230K sold.

Stonebridge Financial Group first reported a position in VRTX in Q2 2026 and held it in 1 quarter. The position peaked at $230K in Q2 2026. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Stonebridge Financial Group reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Stonebridge Financial Group sold 465 Vertex Pharmaceuticals shares in Q3 2026, an estimated $230K.
  • Stonebridge Financial Group first reported a position in Vertex Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Stonebridge Financial Group's Vertex Pharmaceuticals position peaked at $230K in Q2 2026.
  • 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Stonebridge Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.